{"id":13662,"date":"2023-12-27T13:11:14","date_gmt":"2023-12-27T04:11:14","guid":{"rendered":"https:\/\/www.globalresearch.co.jp\/reports\/?p=13662"},"modified":"2026-03-16T19:33:23","modified_gmt":"2026-03-16T10:33:23","slug":"primary-biliary-cholangitis-therapeutics-market-gvr","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/","title":{"rendered":"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74"},"content":{"rendered":"<p>\u7b2c1\u7ae0 \u8abf\u67fb\u65b9\u6cd5\u3068\u8abf\u67fb\u7bc4\u56f2<br \/>\n1.1 \u8abf\u67fb\u65b9\u6cd5<br \/>\n1.2 \u8abf\u67fb\u7bc4\u56f2\u3068\u524d\u63d0<br \/>\n1.3 \u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u4e00\u89a7<br \/>\n\u7b2c2\u7ae0 \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<br \/>\n2.1. \u809d\u75be\u60a3\u6cbb\u7642\u85ac &#8211; \u7523\u696d\u306e\u6982\u8981\u3068\u4e3b\u8981\u306a\u8cfc\u8cb7\u57fa\u6e96\u30012012\u5e74\uff5e2022\u5e74<br \/>\n\u7b2c3\u7ae0.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u696d\u754c\u306e\u5c55\u671b<br \/>\n\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n3.2.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u304a\u3088\u3073\u6210\u9577\u898b\u901a\u3057\uff082012\u5e74\uff5e2022\u5e74<br \/>\n\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<br \/>\n\u5e02\u5834\u4fc3\u9032\u8981\u56e0\u5206\u6790<br \/>\n3.3.2. \u5e02\u5834\u963b\u5bb3\u8981\u56e0\u5206\u6790<br \/>\n3.4.\u512a\u5148\u9806\u4f4d\u4ed8\u3051\u3055\u308c\u305f\u4e3b\u8981\u6a5f\u4f1a<br \/>\n3.5. \u7523\u696d\u5206\u6790-\u30dd\u30fc\u30bf\u30fc\u306e\u5206\u6790<br \/>\n3.6. \u809d\u75be\u60a3\u6cbb\u7642\u85ac\uff1a\u4f01\u696d\u5e02\u5834\u30b7\u30a7\u30a2\uff082014\u5e74<br \/>\n3.7. \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834PESTEL\u5206\u6790\uff082014\u5e74<br \/>\n\u7b2c4\u7ae0 \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u88fd\u54c1\u5c55\u671b<br \/>\n4.1 \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u88fd\u54c1\u5225\u5e02\u5834\u30b7\u30a7\u30a2\uff082014\u5e74\u30fb2022\u5e74<br \/>\n4.2 \u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u5e02\u5834\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n4.3 \u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\u30012012\u5e74\uff5e2022\u5e74\uff08USD Million\uff09<br \/>\n\u5316\u5b66\u7642\u6cd5\u5e02\u5834\u306e2012\u5e74\uff5e2022\u5e74\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\uff08USD Million\uff09<br \/>\n4.5 \u6a19\u7684\u7642\u6cd5\u5e02\u5834\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\u30012012\u5e74\uff5e2022\u5e74\uff08USD Million\uff09<br \/>\n4.6 \u514d\u75ab\u6291\u5236\u5264\u5e02\u5834\u306e2012\u5e74\uff5e2022\u5e74\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\uff08USD Million\uff09<br \/>\n4.7 \u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u5e02\u5834\u306e2012\uff5e2022\u5e74\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n4.8 \u526f\u814e\u76ae\u8cea\u30b9\u30c6\u30ed\u30a4\u30c9\u5e02\u5834\u306e2012\u5e74\uff5e2022\u5e74\u306e\u63a8\u5b9a\u3068\u4e88\u6e2c\uff08USD Million\uff09<br \/>\n\u7b2c5\u7ae0 \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u5730\u57df\u5225\u5c55\u671b<br \/>\n5.1 \u5317\u7c73<br \/>\n5.1.1. \u5317\u7c73\u5e02\u5834\u3001\u88fd\u54c1\u5225\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n\u6b27\u5dde<br \/>\n\u6b27\u5dde\u5e02\u5834\u3001\u88fd\u54c1\u5225\u30012012\u5e74\uff5e2022\u5e74 (\u767e\u4e07\u7c73\u30c9\u30eb)<br \/>\n5.3.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<br \/>\n\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5e02\u5834\u3001\u88fd\u54c1\u5225\u30012012\u5e74\uff5e2022\u5e74 (\u767e\u4e07\u7c73\u30c9\u30eb)<br \/>\n5.4.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df<br \/>\n\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u5e02\u5834\u3001\u88fd\u54c1\u5225\u30012012\u5e74\uff5e2022\u5e74 (\u767e\u4e07\u7c73\u30c9\u30eb)<br \/>\n\u7b2c6\u7ae0 \u7af6\u4e89\u74b0\u5883<br \/>\n\u30a2\u30dc\u30c3\u30c8\u30fb\u30e9\u30dc\u30e9\u30c8\u30ea\u30fc\u30ba<br \/>\n\u4f1a\u793e\u6982\u8981<br \/>\n6.1.2. \u8ca1\u52d9\u5b9f\u7e3e<br \/>\n6.1.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.1.4. \u6226\u7565\u7684\u53d6\u308a\u7d44\u307f<br \/>\n6.2. \u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e<br \/>\n6.2.1.\u4f1a\u793e\u6982\u8981<br \/>\n6.2.2. \u696d\u7e3e<br \/>\n6.2.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.2.4.\u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.3. \u30d6\u30ea\u30b9\u30c8\u30eb\u30fb\u30e1\u30a4\u30e4\u30fc\u30ba \u30b9\u30af\u30a4\u30d6<br \/>\n6.3.1 \u4f1a\u793e\u6982\u8981<br \/>\n6.3.2. \u696d\u7e3e<br \/>\n6.3.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.3.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.4. \u30ae\u30ea\u30a2\u30c9\u30fb\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba<br \/>\n6.4.1 \u4f1a\u793e\u6982\u8981<br \/>\n6.4.2. \u696d\u7e3e<br \/>\n6.4.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.4.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.5 \u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9<br \/>\n6.5.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.5.2. \u696d\u7e3e<br \/>\n6.5.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.5.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.6. \u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5\u793e<br \/>\n6.6.1 \u4f1a\u793e\u6982\u8981<br \/>\n6.6.2. \u696d\u7e3e<br \/>\n6.6.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.6.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.7. Merck &amp; Co.Inc.<br \/>\n6.7.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.7.2. \u696d\u7e3e<br \/>\n6.7.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.7.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.8 \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9AG<br \/>\n6.8.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.8.2. \u696d\u7e3e<br \/>\n6.8.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.8.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.9. \u30b5\u30ce\u30d5\u30a3S.A.<br \/>\n6.9.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.9.2. \u696d\u7e3e<br \/>\n6.9.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.9.4. \u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<br \/>\n6.10. \u30d5\u30a1\u30a4\u30b6\u30fc<br \/>\n6.10.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.10.2. \u696d\u7e3e<br \/>\n6.10.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.10.4. \u6226\u7565\u7684\u53d6\u308a\u7d44\u307f<br \/>\n6.11. \u6b66\u7530\u85ac\u54c1\u5de5\u696d<br \/>\n6.11.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.11.2. \u696d\u7e3e<br \/>\n6.11.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.11.4. \u6226\u7565\u7684\u53d6\u308a\u7d44\u307f<br \/>\n6.12. \u30f4\u30a1\u30ec\u30a2\u30f3\u30c8\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba<br \/>\n6.12.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.12.2. \u696d\u7e3e<br \/>\n6.12.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.12.4. \u6226\u7565\u7684\u53d6\u308a\u7d44\u307f<br \/>\n6.13. \u30ef\u30c8\u30bd\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba<br \/>\n6.13.1. \u4f1a\u793e\u6982\u8981<br \/>\n6.13.2. \u696d\u7e3e<br \/>\n6.13.3. \u88fd\u54c1\u30d9\u30f3\u30c1\u30de\u30fc\u30af<br \/>\n6.13.4. \u6226\u7565\u7684\u53d6\u308a\u7d44\u307f<\/p>\n<p>\u30c6\u30fc\u30d6\u30eb\u4e00\u89a7<\/p>\n<p>1.\u809d\u75be\u60a3\u6cbb\u7642\u85ac-\u7523\u696d\u30b9\u30ca\u30c3\u30d7\u30b7\u30e7\u30c3\u30c8<br \/>\n2.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u3001\u88fd\u54c1\u5225\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n3.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\uff1a\u5730\u57df\u5225\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n4.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834 &#8211; \u4e3b\u306a\u5e02\u5834\u4fc3\u9032\u8981\u56e0\u5206\u6790<br \/>\n5.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834 &#8211; \u4e3b\u306a\u5e02\u5834\u6291\u5236\u8981\u56e0\u5206\u6790<br \/>\n6.\u5317\u7c73\u306e\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\uff1a\u88fd\u54c1\u5225\u30012012\u5e74\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n7.\u6b27\u5dde \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\uff1a\u88fd\u54c1\u5225\u30012012\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n8.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\uff1a\u88fd\u54c1\u5225\u30012012\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n9.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df \u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\uff1a\u88fd\u54c1\u5225\u30012012\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<\/p>\n<p>\u56f3\u8868\u4e00\u89a7<\/p>\n<p>1.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n2.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\u53ce\u76ca\u30012012\u5e74\uff5e2022\u5e74<br \/>\n3.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<br \/>\n4.\u512a\u5148\u3055\u308c\u308b\u4e3b\u306a\u6a5f\u4f1a<br \/>\n5.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u5206\u6790-\u30dd\u30fc\u30bf\u30fc\u306e\u5206\u6790<br \/>\n6.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u5206\u6790-PESTEL\u5206\u6790<br \/>\n7.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834 , \u88fd\u54c1\u5225, 2012 &#8211; 2022 (\u767e\u4e07\u7c73\u30c9\u30eb)<br \/>\n8.\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u5e02\u5834\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n9.\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n10.\u5316\u5b66\u7642\u6cd5\u5e02\u5834\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n11.\u6a19\u7684\u7642\u6cd5\u5e02\u5834\u30012012\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n12.\u514d\u75ab\u6291\u5236\u5264\u5e02\u5834\u30012012\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n13.\u514d\u75ab\u30b0\u30ed\u30d6\u30ea\u30f3\u5e02\u5834\u30012012\u5e74\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n14.\u526f\u814e\u76ae\u8cea\u30db\u30eb\u30e2\u30f3\u5e02\u5834\u30012012\uff5e2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n15.\u809d\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\uff1a2012\u301c2022\u5e74\u5730\u57df\u5225\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n16.\u5317\u7c73\u5e02\u5834\u30012012\u301c2022\u5e74\uff1a\u88fd\u54c1\u5225\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n17.\u6b27\u5dde\u5e02\u5834\uff1a2012\u301c2022\u5e74\uff1a\u88fd\u54c1\u5225\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n18.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5e02\u5834\uff1a2012\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<br \/>\n19.\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u5e02\u5834\uff1a2012\u301c2022\u5e74\uff08\u767e\u4e07\u7c73\u30c9\u30eb\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5e02\u5834\u898f\u6a21\u3068\u52d5\u5411<br \/>\n\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\u898f\u6a21\u306f2022\u5e74\u306b6\u51048650\u4e07\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff097.5\uff05\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u306f\u3001\u5c0f\u80c6\u7ba1\u3092\u4fb5\u3059\u81ea\u5df1\u514d\u75ab\u6027\u809d\u75be\u60a3\u3067\u3042\u308b\u3002\u3053\u306e\u75be\u60a3\u306f\u3001\u80c6\u7ba1\u304c\u5f90\u3005\u306b\u60aa\u5316\u3057\u3001\u80c6\u6c41\u306e\u6d41\u308c\u304c\u60aa\u304f\u306a\u308a\u3001\u809d\u81d3\u306b\u5bb3\u3092\u53ca\u307c\u3059\u3053\u3068\u3092\u7279\u5fb4\u3068\u3059\u308b\u3002PBC\u306e\u6b63\u78ba\u306a\u539f\u56e0\u306f\u307e\u3060\u7279\u5b9a\u3055\u308c\u3066\u3044\u306a\u3044\u304c\u3001\u907a\u4f1d\u7684\u3001\u74b0\u5883\u7684\u3001\u514d\u75ab\u7cfb\u7684\u8981\u7d20\u304b\u3089\u751f\u3058\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u308b\u3002\u7279\u5b9a\u306e\u907a\u4f1d\u7684\u7d20\u56e0\u3084\u3001\u611f\u67d3\u75c7\u3084\u6709\u5bb3\u7269\u8cea\u3078\u306e\u66b4\u9732\u306a\u3069\u306e\u74b0\u5883\u7684\u8a98\u56e0\u304c\u767a\u75c7\u306b\u95a2\u4e0e\u3057\u3066\u3044\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002<\/p>\n<p>\u88fd\u85ac\u696d\u754c\u306f\u3001PBC\u306e\u6839\u672c\u7684\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u3088\u308a\u6df1\u304f\u7406\u89e3\u3057\u3001\u52b9\u679c\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u751f\u307f\u51fa\u3059\u305f\u3081\u306b\u3001\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u306b\u7a4d\u6975\u7684\u306b\u6295\u8cc7\u3057\u3066\u3044\u308b\u3002\u3053\u308c\u306b\u306f\u3001\u65b0\u85ac\u306e\u63a2\u7d22\u3001\u6cbb\u7642\u6cd5\u306e\u7d44\u307f\u5408\u308f\u305b\u3001\u52b9\u679c\u7684\u306a\u81e8\u5e8a\u8a66\u9a13\u306a\u3069\u304c\u542b\u307e\u308c\u308b\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u6ce8\u76ee\u306e\u9ad8\u307e\u308a\u304c\u3001\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3051\u308b\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u62e1\u5927\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u533b\u85ac\u54c1\u88fd\u9020\u30fb\u6d41\u901a\u3092\u542b\u3080\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306f\u3001COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306b\u3088\u308b\u6df7\u4e71\u306e\u5f71\u97ff\u3092\u53d7\u3051\u305f\u3002\u8f38\u51fa\u5165\u3092\u542b\u3080\u79fb\u52d5\u5236\u9650\u306e\u767a\u52d5\u3084\u88fd\u9020\u5de5\u5834\u306e\u80fd\u529b\u4f4e\u4e0b\u306f\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u6cbb\u7642\u85ac\u306e\u88fd\u9020\u30fb\u6d41\u901a\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001COVID-19\u306e\u6d41\u884c\u306f\u5e02\u5834\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002<\/p>\n<p>\u85ac\u5264\u30bf\u30a4\u30d7\u5225\u30a4\u30f3\u30b5\u30a4\u30c8<br \/>\n\u85ac\u5264\u30bf\u30a4\u30d7\u306b\u57fa\u3065\u304d\u3001\u5e02\u5834\u306f\u4e00\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u3068\u4e8c\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u306b\u533a\u5206\u3055\u308c\u308b\u3002\u4e00\u6b21\u85ac\u7269\u30bf\u30a4\u30d7\u306f\u3001PBC\u306e\u6cbb\u7642\u306b\u4e00\u6b21\u85ac\u7269\u304c\u5e83\u304f\u4f7f\u7528\u3055\u308c\u3066\u304a\u308a\u3001\u75be\u60a3\u306b\u5bfe\u3059\u308b\u6709\u52b9\u6027\u304c\u5b9f\u8a3c\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u30012022\u5e74\u306b\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u305f\u3002<\/p>\n<p>\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u306e\u6d1e\u5bdf<br \/>\n\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u306b\u3001\u5e02\u5834\u306f\u75c5\u9662\u85ac\u5c40\u3001\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306b\u533a\u5206\u3055\u308c\u308b\u30022022\u5e74\u306f\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u306f2023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u6700\u3082\u901f\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u3053\u308c\u306f\u3001\u30a4\u30f3\u30bf\u30fc\u30cd\u30c3\u30c8\u306e\u666e\u53ca\u3001\u4f7f\u3044\u3084\u3059\u3055\u3001\u652f\u6255\u3044\u30e2\u30c7\u30eb\u306e\u7c21\u4fbf\u3055\u3001\u305d\u3057\u3066\u5168\u4f53\u3068\u3057\u3066\u6025\u6210\u9577\u3057\u3066\u3044\u308b\u96fb\u5b50\u5546\u53d6\u5f15\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u52a0\u3048\u3001\u307b\u3068\u3093\u3069\u306e\u96fb\u5b50\u5546\u53d6\u5f15\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u63d0\u4f9b\u3059\u308b\u8ca9\u4fc3\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u3084\u5272\u5f15\u304c\u8981\u56e0\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u308b\u3002<\/p>\n<p>\u5730\u57df\u30a4\u30f3\u30b5\u30a4\u30c8<br \/>\n2022\u5e74\u306b\u306f\u5317\u7c73\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u5927\u898f\u6a21\u306a\u60a3\u8005\u30d7\u30fc\u30eb\u3068\u78ba\u7acb\u3055\u308c\u305f\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u5b58\u5728\u304c\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u3055\u3089\u306b\u5f37\u5316\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u540c\u5730\u57df\u3067\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5897\u52a0\u3001\u9ad8\u5ea6\u533b\u7642\u65bd\u8a2d\u306e\u5229\u7528\u53ef\u80fd\u6027\u3001\u653f\u5e9c\u6a5f\u95a2\u306b\u3088\u308b\u591a\u984d\u306e\u533b\u7642\u6295\u8cc7\u304c\u5e02\u5834\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u3002\u3055\u3089\u306b\u3001\u6709\u5229\u306a\u511f\u9084\u5236\u5ea6\u306b\u3088\u308a\u3001\u60a3\u8005\u306e\u81ea\u5df1\u8ca0\u62c5\u984d\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u305f\u3081\u3001\u591a\u304f\u306e\u60a3\u8005\u304c\u6cbb\u7642\u3092\u5229\u7528\u3057\u3084\u3059\u304f\u306a\u3063\u3066\u3044\u308b\u3002<\/p>\n<p>\u4e3b\u8981\u4f01\u696d\u3068\u5e02\u5834\u30b7\u30a7\u30a2<br \/>\n\u4e3b\u306a\u53c2\u5165\u4f01\u696d\u306f\u3001Lupin\u3001ABC Farmaceutici S.p.a.\u3001Intercept Pharmaceuticals, Inc.\u3001Alkem Laboratories Limited\u3001GENFIT\u3001Leeford Healthcare Ltd.\u3001Ipsen Pharma\u3001Zydus Lifesciences Limited\u3001Sun Pharmaceutical Industries Ltd.\u306a\u3069\u3067\u3042\u308b\u3002\u4ee5\u4e0b\u306f\u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306e\u4f8b\u3067\u3042\u308b\uff1a<\/p>\n<p>2023\u5e743\u6708\u3001Ipsen Pharma\u793e\u306fAlbireo Pharma\u793e\u3092\u8cb7\u53ce\u3057\u305f\u3002Albireo\u793e\u306f\u3001\u5e0c\u5c11\u306a\u809d\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u80c6\u6c41\u9178\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\u306e\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30fb\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3067\u3042\u308b\u3002\u3053\u306e\u8cb7\u53ce\u306b\u3088\u308a\u3001Ipsen \u306e\u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u88fd\u54c1\u30e9\u30a4\u30f3\u30a2\u30c3\u30d7\u304c\u62e1\u5927\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u308b\u3002<\/p>\n<p>2022\u5e745\u6708\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u30fb\u30d5\u30a1\u30fc\u30de\u306f\u30a4\u30f3\u30bf\u30fc\u30bb\u30d7\u30c8\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304b\u3089\u3044\u304f\u3064\u304b\u306e\u88fd\u54c1\u306e\u6a29\u5229\u3092\u53d6\u5f97\u3057\u305f\u3002\u3053\u308c\u306b\u306f\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u304c\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u30aa\u30ab\u30ea\u30d0\u3092\u7c73\u56fd\u5916\u3067\u5546\u696d\u5316\u3059\u308b\u6a29\u5229\u3082\u542b\u307e\u308c\u308b\u3002<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74\" \/>\n<meta property=\"og:description\" content=\"\u5e02\u5834\u898f\u6a21\u3068\u52d5\u5411 \u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\u898f\u6a21\u306f2022\u5e74\u306b6\u51048650\u4e07\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff097.5\uff05\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u306f\u3001\u5c0f\u80c6\u7ba1\u3092\u4fb5\u3059\u81ea\u5df1\u514d\u75ab\u6027\u809d\u75be\u60a3\u3067\u3042\u308b\u3002\u3053\u306e\u75be\u60a3\u306f\u3001\u80c6\u7ba1\u304c\u5f90\u3005\u306b\u60aa\u5316\u3057\u3001\u80c6\u6c41\u306e\u6d41\u308c\u304c\u60aa\u304f\u306a\u308a\u3001\u809d\u81d3\u306b\u5bb3\u3092\u53ca\u307c\u3059\u3053\u3068\u3092\u7279\u5fb4\u3068\u3059\u308b\u3002PBC\u306e\u6b63\u78ba\u306a\u539f\u56e0\u306f\u307e\u3060\u7279\u5b9a\u3055\u308c\u3066\u3044\u306a\u3044\u304c\u3001\u907a\u4f1d\u7684\u3001\u74b0\u5883\u7684\u3001\u514d\u75ab\u7cfb\u7684\u8981\u7d20\u304b\u3089\u751f\u3058\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u308b\u3002\u7279\u5b9a\u306e\u907a\u4f1d\u7684\u7d20\u56e0\u3084\u3001\u611f\u67d3\u75c7\u3084\u6709\u5bb3\u7269\u8cea\u3078\u306e\u66b4\u9732\u306a\u3069\u306e\u74b0\u5883\u7684\u8a98\u56e0\u304c\u767a\u75c7\u306b\u95a2\u4e0e\u3057\u3066\u3044\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002  \u88fd\u85ac\u696d\u754c\u306f\u3001PBC\u306e\u6839\u672c\u7684\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u3088\u308a\u6df1\u304f\u7406\u89e3\u3057\u3001\u52b9\u679c\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u751f\u307f\u51fa\u3059\u305f\u3081\u306b\u3001\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u306b\u7a4d\u6975\u7684\u306b\u6295\u8cc7\u3057\u3066\u3044\u308b\u3002\u3053\u308c\u306b\u306f\u3001\u65b0\u85ac\u306e\u63a2\u7d22\u3001\u6cbb\u7642\u6cd5\u306e\u7d44\u307f\u5408\u308f\u305b\u3001\u52b9\u679c\u7684\u306a\u81e8\u5e8a\u8a66\u9a13\u306a\u3069\u304c\u542b\u307e\u308c\u308b\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u6ce8\u76ee\u306e\u9ad8\u307e\u308a\u304c\u3001\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3051\u308b\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u62e1\u5927\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002  \u533b\u85ac\u54c1\u88fd\u9020\u30fb\u6d41\u901a\u3092\u542b\u3080\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306f\u3001COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306b\u3088\u308b\u6df7\u4e71\u306e\u5f71\u97ff\u3092\u53d7\u3051\u305f\u3002\u8f38\u51fa\u5165\u3092\u542b\u3080\u79fb\u52d5\u5236\u9650\u306e\u767a\u52d5\u3084\u88fd\u9020\u5de5\u5834\u306e\u80fd\u529b\u4f4e\u4e0b\u306f\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u6cbb\u7642\u85ac\u306e\u88fd\u9020\u30fb\u6d41\u901a\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001COVID-19\u306e\u6d41\u884c\u306f\u5e02\u5834\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002  \u85ac\u5264\u30bf\u30a4\u30d7\u5225\u30a4\u30f3\u30b5\u30a4\u30c8 \u85ac\u5264\u30bf\u30a4\u30d7\u306b\u57fa\u3065\u304d\u3001\u5e02\u5834\u306f\u4e00\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u3068\u4e8c\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u306b\u533a\u5206\u3055\u308c\u308b\u3002\u4e00\u6b21\u85ac\u7269\u30bf\u30a4\u30d7\u306f\u3001PBC\u306e\u6cbb\u7642\u306b\u4e00\u6b21\u85ac\u7269\u304c\u5e83\u304f\u4f7f\u7528\u3055\u308c\u3066\u304a\u308a\u3001\u75be\u60a3\u306b\u5bfe\u3059\u308b\u6709\u52b9\u6027\u304c\u5b9f\u8a3c\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u30012022\u5e74\u306b\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u305f\u3002  \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u306e\u6d1e\u5bdf \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u306b\u3001\u5e02\u5834\u306f\u75c5\u9662\u85ac\u5c40\u3001\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306b\u533a\u5206\u3055\u308c\u308b\u30022022\u5e74\u306f\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u306f2023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u6700\u3082\u901f\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u3053\u308c\u306f\u3001\u30a4\u30f3\u30bf\u30fc\u30cd\u30c3\u30c8\u306e\u666e\u53ca\u3001\u4f7f\u3044\u3084\u3059\u3055\u3001\u652f\u6255\u3044\u30e2\u30c7\u30eb\u306e\u7c21\u4fbf\u3055\u3001\u305d\u3057\u3066\u5168\u4f53\u3068\u3057\u3066\u6025\u6210\u9577\u3057\u3066\u3044\u308b\u96fb\u5b50\u5546\u53d6\u5f15\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u52a0\u3048\u3001\u307b\u3068\u3093\u3069\u306e\u96fb\u5b50\u5546\u53d6\u5f15\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u63d0\u4f9b\u3059\u308b\u8ca9\u4fc3\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u3084\u5272\u5f15\u304c\u8981\u56e0\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u308b\u3002  \u5730\u57df\u30a4\u30f3\u30b5\u30a4\u30c8 2022\u5e74\u306b\u306f\u5317\u7c73\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u5927\u898f\u6a21\u306a\u60a3\u8005\u30d7\u30fc\u30eb\u3068\u78ba\u7acb\u3055\u308c\u305f\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u5b58\u5728\u304c\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u3055\u3089\u306b\u5f37\u5316\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u540c\u5730\u57df\u3067\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5897\u52a0\u3001\u9ad8\u5ea6\u533b\u7642\u65bd\u8a2d\u306e\u5229\u7528\u53ef\u80fd\u6027\u3001\u653f\u5e9c\u6a5f\u95a2\u306b\u3088\u308b\u591a\u984d\u306e\u533b\u7642\u6295\u8cc7\u304c\u5e02\u5834\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u3002\u3055\u3089\u306b\u3001\u6709\u5229\u306a\u511f\u9084\u5236\u5ea6\u306b\u3088\u308a\u3001\u60a3\u8005\u306e\u81ea\u5df1\u8ca0\u62c5\u984d\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u305f\u3081\u3001\u591a\u304f\u306e\u60a3\u8005\u304c\u6cbb\u7642\u3092\u5229\u7528\u3057\u3084\u3059\u304f\u306a\u3063\u3066\u3044\u308b\u3002  \u4e3b\u8981\u4f01\u696d\u3068\u5e02\u5834\u30b7\u30a7\u30a2 \u4e3b\u306a\u53c2\u5165\u4f01\u696d\u306f\u3001Lupin\u3001ABC Farmaceutici S.p.a.\u3001Intercept Pharmaceuticals, Inc.\u3001Alkem Laboratories Limited\u3001GENFIT\u3001Leeford Healthcare Ltd.\u3001Ipsen Pharma\u3001Zydus Lifesciences Limited\u3001Sun Pharmaceutical Industries Ltd.\u306a\u3069\u3067\u3042\u308b\u3002\u4ee5\u4e0b\u306f\u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306e\u4f8b\u3067\u3042\u308b\uff1a  2023\u5e743\u6708\u3001Ipsen Pharma\u793e\u306fAlbireo Pharma\u793e\u3092\u8cb7\u53ce\u3057\u305f\u3002Albireo\u793e\u306f\u3001\u5e0c\u5c11\u306a\u809d\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u80c6\u6c41\u9178\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\u306e\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30fb\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3067\u3042\u308b\u3002\u3053\u306e\u8cb7\u53ce\u306b\u3088\u308a\u3001Ipsen \u306e\u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u88fd\u54c1\u30e9\u30a4\u30f3\u30a2\u30c3\u30d7\u304c\u62e1\u5927\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u308b\u3002  2022\u5e745\u6708\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u30fb\u30d5\u30a1\u30fc\u30de\u306f\u30a4\u30f3\u30bf\u30fc\u30bb\u30d7\u30c8\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304b\u3089\u3044\u304f\u3064\u304b\u306e\u88fd\u54c1\u306e\u6a29\u5229\u3092\u53d6\u5f97\u3057\u305f\u3002\u3053\u308c\u306b\u306f\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u304c\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u30aa\u30ab\u30ea\u30d0\u3092\u7c73\u56fd\u5916\u3067\u5546\u696d\u5316\u3059\u308b\u6a29\u5229\u3082\u542b\u307e\u308c\u308b\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/\" \/>\n<meta property=\"og:site_name\" content=\"H&amp;I Global Research\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-27T04:11:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-16T10:33:23+00:00\" \/>\n<meta name=\"author\" content=\"marketresearch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketresearch\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/\",\"url\":\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/\",\"name\":\"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74\",\"isPartOf\":{\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/#website\"},\"datePublished\":\"2023-12-27T04:11:14+00:00\",\"dateModified\":\"2026-03-16T10:33:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/a739177802fb08e54e31dc2441082835\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.globalresearch.co.jp\/reports\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/#website\",\"url\":\"https:\/\/www.globalresearch.co.jp\/reports\/\",\"name\":\"H&I Global Research\",\"description\":\"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u8abf\u67fb\u30fb\u7523\u696d\u8cc7\u6599\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.globalresearch.co.jp\/reports\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/a739177802fb08e54e31dc2441082835\",\"name\":\"marketresearch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b288689ac8a046aa448becee0db6379e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b288689ac8a046aa448becee0db6379e?s=96&d=mm&r=g\",\"caption\":\"marketresearch\"},\"url\":\"https:\/\/www.globalresearch.co.jp\/reports\/author\/marketresearch\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/","og_locale":"ja_JP","og_type":"article","og_title":"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74","og_description":"\u5e02\u5834\u898f\u6a21\u3068\u52d5\u5411 \u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u4e16\u754c\u5e02\u5834\u898f\u6a21\u306f2022\u5e74\u306b6\u51048650\u4e07\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff097.5\uff05\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u306f\u3001\u5c0f\u80c6\u7ba1\u3092\u4fb5\u3059\u81ea\u5df1\u514d\u75ab\u6027\u809d\u75be\u60a3\u3067\u3042\u308b\u3002\u3053\u306e\u75be\u60a3\u306f\u3001\u80c6\u7ba1\u304c\u5f90\u3005\u306b\u60aa\u5316\u3057\u3001\u80c6\u6c41\u306e\u6d41\u308c\u304c\u60aa\u304f\u306a\u308a\u3001\u809d\u81d3\u306b\u5bb3\u3092\u53ca\u307c\u3059\u3053\u3068\u3092\u7279\u5fb4\u3068\u3059\u308b\u3002PBC\u306e\u6b63\u78ba\u306a\u539f\u56e0\u306f\u307e\u3060\u7279\u5b9a\u3055\u308c\u3066\u3044\u306a\u3044\u304c\u3001\u907a\u4f1d\u7684\u3001\u74b0\u5883\u7684\u3001\u514d\u75ab\u7cfb\u7684\u8981\u7d20\u304b\u3089\u751f\u3058\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u308b\u3002\u7279\u5b9a\u306e\u907a\u4f1d\u7684\u7d20\u56e0\u3084\u3001\u611f\u67d3\u75c7\u3084\u6709\u5bb3\u7269\u8cea\u3078\u306e\u66b4\u9732\u306a\u3069\u306e\u74b0\u5883\u7684\u8a98\u56e0\u304c\u767a\u75c7\u306b\u95a2\u4e0e\u3057\u3066\u3044\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002  \u88fd\u85ac\u696d\u754c\u306f\u3001PBC\u306e\u6839\u672c\u7684\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u3088\u308a\u6df1\u304f\u7406\u89e3\u3057\u3001\u52b9\u679c\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u751f\u307f\u51fa\u3059\u305f\u3081\u306b\u3001\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u306b\u7a4d\u6975\u7684\u306b\u6295\u8cc7\u3057\u3066\u3044\u308b\u3002\u3053\u308c\u306b\u306f\u3001\u65b0\u85ac\u306e\u63a2\u7d22\u3001\u6cbb\u7642\u6cd5\u306e\u7d44\u307f\u5408\u308f\u305b\u3001\u52b9\u679c\u7684\u306a\u81e8\u5e8a\u8a66\u9a13\u306a\u3069\u304c\u542b\u307e\u308c\u308b\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u6ce8\u76ee\u306e\u9ad8\u307e\u308a\u304c\u3001\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3051\u308b\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u62e1\u5927\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002  \u533b\u85ac\u54c1\u88fd\u9020\u30fb\u6d41\u901a\u3092\u542b\u3080\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306f\u3001COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306b\u3088\u308b\u6df7\u4e71\u306e\u5f71\u97ff\u3092\u53d7\u3051\u305f\u3002\u8f38\u51fa\u5165\u3092\u542b\u3080\u79fb\u52d5\u5236\u9650\u306e\u767a\u52d5\u3084\u88fd\u9020\u5de5\u5834\u306e\u80fd\u529b\u4f4e\u4e0b\u306f\u3001\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u6cbb\u7642\u85ac\u306e\u88fd\u9020\u30fb\u6d41\u901a\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001COVID-19\u306e\u6d41\u884c\u306f\u5e02\u5834\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u305f\u3002  \u85ac\u5264\u30bf\u30a4\u30d7\u5225\u30a4\u30f3\u30b5\u30a4\u30c8 \u85ac\u5264\u30bf\u30a4\u30d7\u306b\u57fa\u3065\u304d\u3001\u5e02\u5834\u306f\u4e00\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u3068\u4e8c\u6b21\u85ac\u5264\u30bf\u30a4\u30d7\u306b\u533a\u5206\u3055\u308c\u308b\u3002\u4e00\u6b21\u85ac\u7269\u30bf\u30a4\u30d7\u306f\u3001PBC\u306e\u6cbb\u7642\u306b\u4e00\u6b21\u85ac\u7269\u304c\u5e83\u304f\u4f7f\u7528\u3055\u308c\u3066\u304a\u308a\u3001\u75be\u60a3\u306b\u5bfe\u3059\u308b\u6709\u52b9\u6027\u304c\u5b9f\u8a3c\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u30012022\u5e74\u306b\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u305f\u3002  \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u306e\u6d1e\u5bdf \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u306b\u3001\u5e02\u5834\u306f\u75c5\u9662\u85ac\u5c40\u3001\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306b\u533a\u5206\u3055\u308c\u308b\u30022022\u5e74\u306f\u30c9\u30e9\u30c3\u30b0\u30b9\u30c8\u30a2\u30fb\u5c0f\u58f2\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u30bb\u30b0\u30e1\u30f3\u30c8\u306f2023\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u6700\u3082\u901f\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u3053\u308c\u306f\u3001\u30a4\u30f3\u30bf\u30fc\u30cd\u30c3\u30c8\u306e\u666e\u53ca\u3001\u4f7f\u3044\u3084\u3059\u3055\u3001\u652f\u6255\u3044\u30e2\u30c7\u30eb\u306e\u7c21\u4fbf\u3055\u3001\u305d\u3057\u3066\u5168\u4f53\u3068\u3057\u3066\u6025\u6210\u9577\u3057\u3066\u3044\u308b\u96fb\u5b50\u5546\u53d6\u5f15\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u52a0\u3048\u3001\u307b\u3068\u3093\u3069\u306e\u96fb\u5b50\u5546\u53d6\u5f15\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u63d0\u4f9b\u3059\u308b\u8ca9\u4fc3\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u3084\u5272\u5f15\u304c\u8981\u56e0\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u308b\u3002  \u5730\u57df\u30a4\u30f3\u30b5\u30a4\u30c8 2022\u5e74\u306b\u306f\u5317\u7c73\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u3002\u5927\u898f\u6a21\u306a\u60a3\u8005\u30d7\u30fc\u30eb\u3068\u78ba\u7acb\u3055\u308c\u305f\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u5b58\u5728\u304c\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u3055\u3089\u306b\u5f37\u5316\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u308b\u3002\u540c\u5730\u57df\u3067\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5897\u52a0\u3001\u9ad8\u5ea6\u533b\u7642\u65bd\u8a2d\u306e\u5229\u7528\u53ef\u80fd\u6027\u3001\u653f\u5e9c\u6a5f\u95a2\u306b\u3088\u308b\u591a\u984d\u306e\u533b\u7642\u6295\u8cc7\u304c\u5e02\u5834\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u3002\u3055\u3089\u306b\u3001\u6709\u5229\u306a\u511f\u9084\u5236\u5ea6\u306b\u3088\u308a\u3001\u60a3\u8005\u306e\u81ea\u5df1\u8ca0\u62c5\u984d\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u305f\u3081\u3001\u591a\u304f\u306e\u60a3\u8005\u304c\u6cbb\u7642\u3092\u5229\u7528\u3057\u3084\u3059\u304f\u306a\u3063\u3066\u3044\u308b\u3002  \u4e3b\u8981\u4f01\u696d\u3068\u5e02\u5834\u30b7\u30a7\u30a2 \u4e3b\u306a\u53c2\u5165\u4f01\u696d\u306f\u3001Lupin\u3001ABC Farmaceutici S.p.a.\u3001Intercept Pharmaceuticals, Inc.\u3001Alkem Laboratories Limited\u3001GENFIT\u3001Leeford Healthcare Ltd.\u3001Ipsen Pharma\u3001Zydus Lifesciences Limited\u3001Sun Pharmaceutical Industries Ltd.\u306a\u3069\u3067\u3042\u308b\u3002\u4ee5\u4e0b\u306f\u6226\u7565\u7684\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306e\u4f8b\u3067\u3042\u308b\uff1a  2023\u5e743\u6708\u3001Ipsen Pharma\u793e\u306fAlbireo Pharma\u793e\u3092\u8cb7\u53ce\u3057\u305f\u3002Albireo\u793e\u306f\u3001\u5e0c\u5c11\u306a\u809d\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u80c6\u6c41\u9178\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\u306e\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30fb\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3067\u3042\u308b\u3002\u3053\u306e\u8cb7\u53ce\u306b\u3088\u308a\u3001Ipsen \u306e\u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u88fd\u54c1\u30e9\u30a4\u30f3\u30a2\u30c3\u30d7\u304c\u62e1\u5927\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u308b\u3002  2022\u5e745\u6708\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u30fb\u30d5\u30a1\u30fc\u30de\u306f\u30a4\u30f3\u30bf\u30fc\u30bb\u30d7\u30c8\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304b\u3089\u3044\u304f\u3064\u304b\u306e\u88fd\u54c1\u306e\u6a29\u5229\u3092\u53d6\u5f97\u3057\u305f\u3002\u3053\u308c\u306b\u306f\u3001\u30a2\u30c9\u30d0\u30f3\u30c4\u304c\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u30aa\u30ab\u30ea\u30d0\u3092\u7c73\u56fd\u5916\u3067\u5546\u696d\u5316\u3059\u308b\u6a29\u5229\u3082\u542b\u307e\u308c\u308b\u3002","og_url":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/","og_site_name":"H&I Global Research","article_published_time":"2023-12-27T04:11:14+00:00","article_modified_time":"2026-03-16T10:33:23+00:00","author":"marketresearch","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"marketresearch"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/","url":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/","name":"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74","isPartOf":{"@id":"https:\/\/www.globalresearch.co.jp\/reports\/#website"},"datePublished":"2023-12-27T04:11:14+00:00","dateModified":"2026-03-16T10:33:23+00:00","author":{"@id":"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/a739177802fb08e54e31dc2441082835"},"breadcrumb":{"@id":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.globalresearch.co.jp\/reports\/primary-biliary-cholangitis-therapeutics-market-gvr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.globalresearch.co.jp\/reports\/"},{"@type":"ListItem","position":2,"name":"\u539f\u767a\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u52d5\u5411\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u85ac\u7269\u30bf\u30a4\u30d7\u5225\uff08\u4e00\u6b21\u6cbb\u7642\u85ac\u3001\u4e8c\u6b21\u6cbb\u7642\u85ac\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\u3001\u5730\u57df\u5225\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u4e88\u6e2c\u30012023\u5e74\uff5e2030\u5e74"}]},{"@type":"WebSite","@id":"https:\/\/www.globalresearch.co.jp\/reports\/#website","url":"https:\/\/www.globalresearch.co.jp\/reports\/","name":"H&I Global Research","description":"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u8abf\u67fb\u30fb\u7523\u696d\u8cc7\u6599\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.globalresearch.co.jp\/reports\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/a739177802fb08e54e31dc2441082835","name":"marketresearch","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.globalresearch.co.jp\/reports\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b288689ac8a046aa448becee0db6379e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b288689ac8a046aa448becee0db6379e?s=96&d=mm&r=g","caption":"marketresearch"},"url":"https:\/\/www.globalresearch.co.jp\/reports\/author\/marketresearch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts\/13662"}],"collection":[{"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/comments?post=13662"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts\/13662\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/media?parent=13662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/categories?post=13662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.jp\/reports\/wp-json\/wp\/v2\/tags?post=13662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}